CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,400 | 468,707 | ||
| 2026-11-05 | Schlanger David J Executive Chairman | Option exercise 10b5-1 | +3,400 | $0.91 | $3K | 241,862 |
| 2026-11-05 | Schlanger David J Executive Chairman | Sale 10b5-1 | −3,400 | $35.22 | $120K | 238,462 |
| 2026-11-05 | Schlanger David J Executive Chairman | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,400 | 228,828 | ||
| 2026-11-04 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,139 | $30.00 | $64K | 70,314 |
| 2026-11-02 | Swartz Allison EVP, GC | Grant or award | +8,160 | 83,976 | ||
| 2026-11-02 | Swartz Allison EVP, GC | Grant or award · Stock Option (Right to Buy) | +11,370 | 11,370 | ||
| 2026-10-14 | Cummings Melissa B Chief Operating Officer | Shares withheld for taxes 10b5-1 | −1,559 | $27.39 | $43K | 68,375 |
| 2026-10-14 | Cummings Melissa B Chief Operating Officer | Sale 10b5-1 | −1,879 | $28.00 | $53K | 66,496 |
| 2026-09-23 | Swartz Allison EVP, GC | Sale 10b5-1 | −3,903 | $26.10 | $102K | 75,816 |
| 2026-09-17 | Clapp Geoffrey Chief Product Officer | Shares withheld for taxes | −819 | $27.38 | $22K | 59,009 |
| 2026-09-10 | GORDON KEVIN K Director | Option exercise | +22,000 | $13.00 | $286K | 28,792 |
| 2026-09-10 | GORDON KEVIN K Director | Shares withheld for taxes | −10,500 | $27.24 | $286K | 18,292 |
| 2026-09-10 | GORDON KEVIN K Director | Sale | −11,500 | $27.12 | $312K | 6,792 |
| 2026-09-10 | GORDON KEVIN K Director | Option exercise · Stock Option (Right to Buy) | −22,000 | 22,000 | ||
| 2026-09-10 | GORDON KEVIN K Director | Option exercise | +22,000 | $13.00 | $286K | 28,792 |
| 2026-09-10 | GORDON KEVIN K Director | Shares withheld for taxes | −10,500 | $27.24 | $286K | 18,292 |
| 2026-09-10 | GORDON KEVIN K Director | Sale | −11,500 | $27.94 | $321K | 6,792 |
| 2026-09-10 | GORDON KEVIN K Director | Option exercise · Stock Option (Right to Buy) | −22,000 | 22,000 | ||
| 2026-09-04 | Swartz Allison EVP, GC | Shares withheld for taxes | −479 | $26.61 | $13K | 79,719 |
Page 2 of 25 · 485 trades